1. ホーム
  2. 一覧
論文 特許

論文 - 一覧

  • 10 Hits
  • 検索条件 : 絞込み (MeSH = Antineoplastic Combined Chemotherapy Protocols)
生物種 リソース名 タイトル
ヒト・動物細胞 KGN(RCB1154) Procaspase-Activating Compound-1 Synergizes with TRAIL to Induce Apoptosis in Established Granulosa Cell Tumor Cell Line (KGN) and Explanted Patient Granulosa Cell Tumor Cells In Vitro.
ヒト・動物細胞 HSC-2(RCB1945) A landmark in drug discovery based on complex natural product synthesis.
ヒト・動物細胞 HSC-2(RCB1945) Efficacy of schedule-dependent metronomic S-1 chemotherapy in human oral squamous cell carcinoma cells.
ヒト・動物細胞 PC-9(RCB4455) Identification of optimal dosing schedules of dacomitinib and osimertinib for a phase I/II trial in advanced EGFR-mutant non-small cell lung cancer.
ヒト・動物細胞 HuCCT1(RCB1960) , SSP-25(RCB1293) , RBE(RCB1292) , YSCCC(RCB1549) , TGBC24TKB(RCB1196) , TFK-1(RCB2537) Synergistic antiproliferative effects of an mTOR inhibitor (rad001) plus gemcitabine on cholangiocarcinoma by decreasing choline kinase activity.
ヒト・動物細胞 B901L(RCB3530) Bevacizumab counteracts VEGF-dependent resistance to erlotinib in an EGFR-mutated NSCLC xenograft model.
ヒト・動物細胞 HCT116(RCB2979) Rabeprazole intake does not affect systemic exposure to capecitabine and its metabolites, 5'-deoxy-5-fluorocytidine, 5'-deoxy-5-fluorouridine, and 5-fluorouracil.
ヒト・動物細胞 PANC-1(RCB2095) The G2 checkpoint inhibitor CBP-93872 increases the sensitivity of colorectal and pancreatic cancer cells to chemotherapy.
遺伝子材料 pENTER-EGFR wild-type (RDB15488) , pENTER-EGFR Del19 (RDB15489) , pENTER-EGFR T790M/del19 (RDB15490) , pENTER-EGFR C797S/del19 (RDB15491) , pENTER-EGFR C797S/T790M/del19 (RDB15492) , pENTER-EGFR L858R (RDB15493) , pENTER-EGFR T790M/L858R (RDB15494) , pENTER-EGFR C797S/L858R (RDB15495) , pENTER-EGFR C797S/T790M/L858R (RDB15496). Brigatinib combined with anti-EGFR antibody overcomes osimertinib resistance in EGFR-mutated non-small-cell lung cancer.
ヒト・動物細胞 JHOC-9(RCB2226) , JHOC-5(RCB1520) Notch3 overexpression as potential therapeutic target in advanced stage chemoresistant ovarian cancer.